CME Group stock kpis
Want to see CME full AI Analyst Report?
Total Contract Volume
CME Group reported total contract volume of 2.21B in Q1 2026, up 26.2% from Q4 2025 and up 21.7% year over year. This is the highest value since 2020.
Measures the total number of contracts traded, indicating market activity levels and the company's ability to attract traders.
Total contract volume has accelerated into a recent inflection driven by broad-based international, commodity and financial adoption plus new product activity; management’s commentary (record ADV, global breadth, and prediction-market traction) confirms durable demand. Yet revenue capture is under pressure from rate‑per‑contract compression tied to micro contracts and volume tiering, and momentum could be sensitive to short‑term softness and regulatory uncertainty around tokenization/perpetuals. In short, growth is robust, but monetization and sustainability—not raw volume—are the key investor watchpoints.
CME Total Contract Volume
| Period | Total Contract Volume |
|---|---|
| Q1 2026Mar 31, 2026 | 2.21B |
| Q4 2025Dec 31, 2025 | 1.75B |
| Q3 2025Sep 30, 2025 | 1.62B |
| Q2 2025Jun 30, 2025 | 1.87B |
| Q1 2025Mar 31, 2025 | 1.82B |
| Q4 2024Dec 31, 2024 | 1.63B |
| Q3 2024Sep 30, 2024 | 1.81B |
| Q2 2024Jun 30, 2024 | 1.63B |
| Q1 2024Mar 31, 2024 | 1.61B |
| Q4 2023Dec 31, 2023 | 1.61B |
| Q3 2023Sep 30, 2023 | 1.41B |
| Q2 2023Jun 30, 2023 | 1.42B |
| Q1 2023Mar 31, 2023 | 1.67B |
| Q4 2022Dec 31, 2022 | 1.37B |
| Q3 2022Sep 30, 2022 | 1.44B |
| Q2 2022Jun 30, 2022 | 1.43B |
| Q1 2022Mar 31, 2022 | 1.61B |
| Q4 2021Dec 31, 2021 | 1.31B |
| Q3 2021Sep 30, 2021 | 1.14B |
| Q2 2021Jun 30, 2021 | 1.16B |
| Q1 2021Mar 31, 2021 | 1.33B |
| Q4 2020Dec 31, 2020 | 1.04B |
| Q3 2020Sep 30, 2020 | 998.60M |
| Q2 2020Jun 30, 2020 | 1.11B |
| Q1 2020Mar 31, 2020 | 1.67B |

